NCT03796598View on ClinicalTrials.gov

FMT in Cirrhosis and Hepatic Encephalopathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

December 19, 2023

Study Completion Date

December 20, 2023

Conditions
CirrhosisHepatic Encephalopathy
Interventions
DRUG

Fecal Microbial transplant Capsules

Oral capsules of FMT

DRUG

Fecal Microbial Transplant Enema

FMT enema

OTHER

Placebo

Placebo

Trial Locations (1)

23249-0001

Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03796598 - FMT in Cirrhosis and Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter